输卵管镜对高级别浆液性卵巢癌的早期筛查

IF 2 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Taiwanese Journal of Obstetrics & Gynecology Pub Date : 2025-07-01 DOI:10.1016/j.tjog.2025.03.014

Anthony D. Burtman, John Heusinkveld, Chaur-Dong Hsu, Ravi Goyal

{"title":"输卵管镜对高级别浆液性卵巢癌的早期筛查","authors":"Anthony D. Burtman, John Heusinkveld, Chaur-Dong Hsu, Ravi Goyal","doi":"10.1016/j.tjog.2025.03.014","DOIUrl":null,"url":null,"abstract":"<div><div>High-grade serous carcinoma (HGSC) of the ovary is the most common and lethal subtype of ovarian cancer, representing the deadliest gynecological malignancy. Due to nonspecific symptoms and the absence of an effective screening tool for average-risk patients, most cases are diagnosed at advanced stages. As a result, fewer than 50 % of patients survive beyond five years post-diagnosis. Current screening methods, such as transvaginal ultrasound and CA-125 blood tests, are inadequate for early detection in the general as well as high-risk population. A promising innovation, the falloposcope, is being developed for routine screening, to detect ovarian cancer earlier, improve treatment outcomes, and enhancing survival rates.</div></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"64 4","pages":"Pages 625-628"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Falloposcope for early screening of high-grade serous ovarian carcinoma\",\"authors\":\"Anthony D. Burtman, John Heusinkveld, Chaur-Dong Hsu, Ravi Goyal\",\"doi\":\"10.1016/j.tjog.2025.03.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>High-grade serous carcinoma (HGSC) of the ovary is the most common and lethal subtype of ovarian cancer, representing the deadliest gynecological malignancy. Due to nonspecific symptoms and the absence of an effective screening tool for average-risk patients, most cases are diagnosed at advanced stages. As a result, fewer than 50 % of patients survive beyond five years post-diagnosis. Current screening methods, such as transvaginal ultrasound and CA-125 blood tests, are inadequate for early detection in the general as well as high-risk population. A promising innovation, the falloposcope, is being developed for routine screening, to detect ovarian cancer earlier, improve treatment outcomes, and enhancing survival rates.</div></div>\",\"PeriodicalId\":49449,\"journal\":{\"name\":\"Taiwanese Journal of Obstetrics & Gynecology\",\"volume\":\"64 4\",\"pages\":\"Pages 625-628\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Taiwanese Journal of Obstetrics & Gynecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1028455925001263\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Taiwanese Journal of Obstetrics & Gynecology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1028455925001263","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

卵巢高级别浆液性癌（HGSC）是卵巢癌最常见和最致命的亚型，是最致命的妇科恶性肿瘤。由于非特异性症状和缺乏对平均风险患者的有效筛查工具，大多数病例在晚期被诊断出来。因此，不到50%的患者在诊断后存活超过5年。目前的筛查方法，如经阴道超声和CA-125血液检查，不足以在一般人群和高危人群中早期发现。一种很有前途的创新技术——输卵管镜，正在开发用于常规筛查，以早期发现卵巢癌，改善治疗效果，提高生存率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Falloposcope for early screening of high-grade serous ovarian carcinoma

High-grade serous carcinoma (HGSC) of the ovary is the most common and lethal subtype of ovarian cancer, representing the deadliest gynecological malignancy. Due to nonspecific symptoms and the absence of an effective screening tool for average-risk patients, most cases are diagnosed at advanced stages. As a result, fewer than 50 % of patients survive beyond five years post-diagnosis. Current screening methods, such as transvaginal ultrasound and CA-125 blood tests, are inadequate for early detection in the general as well as high-risk population. A promising innovation, the falloposcope, is being developed for routine screening, to detect ovarian cancer earlier, improve treatment outcomes, and enhancing survival rates.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Taiwanese Journal of Obstetrics & Gynecology OBSTETRICS & GYNECOLOGY-

CiteScore

3.60

自引率

23.80%

发文量

207

审稿时长

4-8 weeks

期刊介绍： Taiwanese Journal of Obstetrics and Gynecology is a peer-reviewed journal and open access publishing editorials, reviews, original articles, short communications, case reports, research letters, correspondence and letters to the editor in the field of obstetrics and gynecology. The aims of the journal are to: 1.Publish cutting-edge, innovative and topical research that addresses screening, diagnosis, management and care in women''s health 2.Deliver evidence-based information 3.Promote the sharing of clinical experience 4.Address women-related health promotion The journal provides comprehensive coverage of topics in obstetrics & gynecology and women''s health including maternal-fetal medicine, reproductive endocrinology/infertility, and gynecologic oncology. Taiwan Association of Obstetrics and Gynecology.